World's Best Scientists 2026 revealed!
E. Jenny Heathcote

E. Jenny Heathcote

D-Index & Metrics

Medicine

D-Index
75
Citations
31320
World Ranking
18984
National Ranking
801

Overview

E. Jenny Heathcote is affiliated with the University of Toronto in Canada and has a research focus within the field of Medicine, with a particular concentration in Surgery. Their work spans several subfields including Oncology, Otorhinolaryngology, Molecular Biology, and Rheumatology.

The scientist has contributed extensively to research on head and neck cancers, especially adenoid cystic carcinoma. Key topics in their research portfolio include:

  • Salivary Gland Tumors Diagnosis and Treatment
  • Head and Neck Cancer Studies
  • Head and Neck Anomalies
  • Colorectal and Anal Carcinomas
  • Chromatin Remodeling and Cancer
  • Pancreatic and Hepatic Oncology Research
  • Bone Tumor Diagnosis and Treatments

Their recent publications illustrate an ongoing engagement with molecular and clinical aspects of cancer research. Notable papers include:

  • Clinical and genomic characterisation of adenoid cystic carcinoma of the head and neck, lung, and breast, 2023, Journal of Clinical Oncology
  • Gene expression patterns in adenoid cystic carcinoma with and without diffuse NOTCH1 intracellular domain (NICD1) immunohistochemistry staining, 2023, Oral Oncology
  • 904P Analysis of TP63 immunohistochemistry scores (IHC) by primary site and between primary and metastatic tumours in adenoid cystic carcinoma (ACC), 2024, Annals of Oncology
  • KDM6A, ARID1A and SETD2 loss-of-function mutations as prognostic biomarkers and their association with sites of metastatic progression in locally-advanced, recurrent or metastatic adenoid cystic carcinoma, 2025, Oral Oncology
  • Association of quality of life with mortality in patients with adenoid cystic carcinoma using an internationally-validated QoL questionnaire (EQ-5D-5L), 2025, Oral Oncology

Publication venues where this scientist has frequently contributed include:

  • Oral Oncology
  • Journal of Clinical Oncology
  • Annals of Oncology
  • Clinical Cancer Research

Frequent co-authors collaborating with E. Jenny Heathcote encompass Robert Metcalf, Samuel Rack, Guy Betts, Kevin J. Harrington, and Karan Patel. Such collaborations highlight an active involvement in multidisciplinary research teams.

Best Publications

  • Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

    Patrick Marcellin;Edward J Gane;Maria Buti;Nezam H Afdhal

  • Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B

    Patrick Marcellin;E Jenny Heathcote;Maria Buti;Ed Gane

  • Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis B

    Stephanos J. Hadziyannis;Nicolaos C. Tassopoulos;E. Jenny Heathcote;Ting-Tsung Chang

  • Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis.

    E. J. Heathcote;M. L. Shiffman;W. G. E. Cooksley;G. M. Dusheiko

  • Long-term safety of lamivudine treatment in patients with chronic hepatitis B.

    Anna S.F. Lok;Ching Lung Lai;Nancy Leung;Guang Bi Yao

  • Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years.

    Stephanos J. Hadziyannis;Nicolaos C. Tassopoulos;E. Jenny Heathcote;Ting–Tsung Chang

  • Telbivudine versus lamivudine in patients with chronic hepatitis B.

    Ching-Lung Lai;Edward Gane;Yun-Fan Liaw;Chao-Wei Hsu

  • Management of hepatitis B: 2000--summary of a workshop.

    Anna S. Lok;E.Jenny Heathcote;Jay H. Hoofnagle

  • Histological outcome during long-term lamivudine therapy.

    Jules L. Dienstag;Robert D. Goldin;E.Jenny Heathcote;H.W.L. Hann

  • 2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B

    Yun–Fan Liaw;Edward Gane;Nancy Leung;Stefan Zeuzem

  • Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.

    Marion G. Peters;H. W. Hann;Paul Martin;E. Jenny Heathcote

  • Sustained Virologic Response and Clinical Outcomes in Patients with Chronic Hepatitis C and Advanced Fibrosis

    Bart J Veldt;E Jenny Heathcote;Heiner Wedemeyer;Juerg Reichen

  • Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B

    Stephanos J. Hadziyannis;Nicolaos C. Tassopoulos;E. Jenny Heathcote;Ting-Tsung Chang

  • Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B

    Jean-Pierre Villeneuve;Lynn D. Condreay;Bernard Willems;Gilles Pomier-Layrargues

  • Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis

    RE Poupon;KD Lindor;K Cauch-Dudek;ER Dickson

  • Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants.

    Gideon M. Hirschfield;Xiangdong Liu;Chun Xu;Yue Lu

  • Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B

    E. Jenny Heathcote;Patrick Marcellin;Maria Buti;Edward Gane

  • Management of primary biliary cirrhosis

    E. Jenny Heathcote

  • The canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis

    E. Jenny Heathcote;Karen Cauch-Dudek;Valery Walker;Robert J. Bailey

  • Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis

    Xiangdong Liu;Pietro Invernizzi;Yue Lu;Roman Kosoy

Frequent Co-Authors

Gideon M. Hirschfield
Gideon M. Hirschfield University Health Network
Stefan Zeuzem
Stefan Zeuzem Goethe University Frankfurt
Antonio Craxì
Antonio Craxì University of Palermo
Patrick Marcellin
Patrick Marcellin Université Paris Cité
Keith D. Lindor
Keith D. Lindor Arizona State University
Edward Gane
Edward Gane Auckland City Hospital
Eugene R. Schiff
Eugene R. Schiff University of Miami
Christopher I. Amos
Christopher I. Amos Baylor College of Medicine
Massimo Colombo
Massimo Colombo Humanitas University
Harry L.A. Janssen
Harry L.A. Janssen Erasmus University Rotterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students exploring alternatives or complementary careers to traditional medical degrees, several flexible and accessible options can be found online. A popular route is pursuing direct entry msn programs online, designed for non-nurses wanting to fast-track into advanced nursing roles. These programs often provide a path to high-demand healthcare positions in less time than traditional tracks.

Getting into nursing can also be more accessible through direct admit nursing programs that offer streamlined admissions processes. Some schools even eliminate testing barriers, with nursing schools that don't require teas or HESI exams, making entry easier for many students.

Those interested in administrative or technical roles in healthcare might consider medical billing and coding schools that accept financial aid. These programs offer flexible online learning and financial support, leading to fulfilling careers that support patient care from behind the scenes.

Best Scientists Citing E. Jenny Heathcote

Trending Scientists

Recently Published Articles